Loomis Sayles & CO L P Organon & Co. Transaction History

Loomis Sayles & CO L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $2,266 - $3,585	207 Added 50.86%	614 $9,000
Q3 2023 Nov 09, 2023	BUY	$16.59 - $23.77 $2,936 - $4,207	177 Added 76.96%	407 $7,000
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $3,372 - $4,310	-175 Reduced 43.21%	230 $5,000
Q1 2023 May 11, 2023	BUY	$21.42 - $32.08 $8,675 - $12,992	405 New	405 $10,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $6,645 - $9,727	-284 Reduced 86.06%	46 $1,000
Q2 2022 Aug 05, 2022	SELL	$31.66 - $38.9 $8,294 - $10,191	-262 Reduced 44.26%	330 $11,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $10,718 - $13,854	352 Added 146.67%	592 $21,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $143 - $185	-5 Reduced 2.04%	240 $7,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1.51 Million - $1.88 Million	-52,786 Reduced 99.54%	245 $8,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $1.51 Million - $2.02 Million	53,031 New	53,031 $1.6 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.